Retina

Michael Ip, MD, presented a large-scale analysis of OCT biomarkers in diabetic macular edema (DME), drawing on data from the DRCR Retina Network's Protocol T trial.

i-Lumen Scientific randomly assigned its first US patient in the sham-controlled i-SIGHT2 pivotal study of its investigational, noninvasive bioelectric AMD device at Texas Retina Associates.

Lab-grown retinal endothelial cells from iPSCs rebuild mouse retinal vessels and power blood-retina barrier chips, accelerating diabetic retinopathy research and therapy discovery.

A midyear look at 2026's biggest optometry findings, from myopia control research to safety signals on red light therapy and semaglutide.

An overview of the diagnosis and evidence-based management of one of the most common causes of visual acuity reduction following intraocular surgery.

In a preference study, Karl Csaky, MD, PhD and colleagues found that lesion growth rate reduction was the primary driver of GA treatment decisions among US retina specialists, with greater risk tolerance for foveal-threatening lesions.

The resubmission is considered a Class 1 submission and has a current PDUFA target action date of July 29, 2026.

A case study that highlights the importance of multimodal imaging in practice for early identification of rare inherited retinal dystrophies.

The study, conducted through the OHDSI network, analyzed records from 227,971 new users of semaglutide.

The benefits of consistent physical activity have been demonstrated for a host of systemic conditions.

The FDA's OND found substantial evidence of effectiveness for bevacizumab-vikg in nAMD, clearing the way for a BLA resubmission in June 2026 and a decision expected within 60 days.

The study reviewed 1440 peer-reviewed journal articles indexed in the Web of Science Core Collection between 2010 and 2025.

Rethinking the optometrist’s role in healthy aging.

New Turkish study links sleeve gastrectomy weight loss to clearer cornea and lens, lower eye pressure, and widened anterior chamber in 6 months.

AMD affects approximately 28 million people in the US and is a leading cause of vision loss among older adults.

Avacincaptad pegol may help preserve driving-related vision in geographic atrophy, but post hoc data did not reach statistical significance.

Ischemic retinal disorders may signal underlying cardiovascular risk, making diagnostic imaging workup essential.

The device is described as “a wireless brain implant designed to provide artificial vision for people with total blindness by bypassing the eyes and optic nerves and connecting directly to the brain’s visual cortex.

ECG-synchronized Doppler holography provides repeatable measurements of the retinal blood flow.

The study, published in PLoS Genetics, examined how glucose metabolism affects gene expression in light-sensing photoreceptors.

Researchers noted growing evidence supporting an additional role for B vitamins.

What to know about the current state of artificial intelligence and multimodal retinal imaging in systemic disease surveillance in eye care.

At 12 weeks, improvements in visual and anatomical outcomes were observed across all groups.

The analysis included 12,183,254 patients, with 304,823 identified as smokers and 11,878,431 as non-smokers.

The decision lengthens the approved treatment period outlined in the prescribing information and may lessen the need to change therapies for patients who continue to show a lasting response.